SCHEMBL17078460

SCHEMBL17078460

CCCCN1[C@H](C)CN(Cc2ccc(C(=O)OC)cc2)C[C@@H]1C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.50
▸ CHKA P35790 1/20 0.48
▸ MAPK1 P28482 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ S1PR5 Q9H228 5/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ S1PR1 P21453 4/20 0.44
▸ S1PR3 Q99500 3/20 0.43
▸ S1PR4 O95977 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17078766 0.93 KDM4E (0.52) KDM4ECHKAMAPK1SMN1; SMN2LMNA
SCHEMBL17078529 0.90 KDM4E (0.47) KDM4ECHKAMAPK1SMN1; SMN2LMNA
SCHEMBL17079065 0.87 KDM4E (0.54) KDM4ECHKAMAPK1SMN1; SMN2LMNA
SCHEMBL17078686 0.86 CHKA (0.45) KDM4ECHKAMAPK1SMN1; SMN2LMNA
SCHEMBL20421024 0.86 S1PR5 (0.52) S1PR5HDAC1HDAC6S1PR1S1PR3
SCHEMBL17078864 0.85 LMNA (0.59) KDM4ECHKAMAPK1SMN1; SMN2S1PR5
SCHEMBL17078602 0.85 HDAC6 (0.62) S1PR5HDAC1HDAC6S1PR1S1PR3
SCHEMBL17078793 0.83 MEN1 (0.54) KDM4ECHKAS1PR5MEN1KMT2A
SCHEMBL17086785 0.82 HDAC1 (0.58) KDM4EMAPK1SMN1; SMN2S1PR5MEN1
SCHEMBL17078685 0.82 HDAC1 (0.58) KDM4EMAPK1SMN1; SMN2S1PR5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2019-05-14 — — US disclosed
EP-3116859-B1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2018-08-01 — — EP disclosed
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2017-04-06 — — US disclosed
EP-3116859-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2017-01-18 — — EP disclosed
WO-2015137750-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-09-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287255-B2 Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same HDAC6, HDAC1, HDAC11 KDM4E 319/4885CHKA 1227/4885MAPK1 2398/4885
US-20170096405-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME HDAC6, HDAC1, HDAC5 KDM4E 468/4885CHKA 636/4885MAPK1 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback